Mental Health Clinics in Gray, GA Accepting Medicare
8 Mental Health Clinics found. Showing 1 - 8
 Settlement Drive Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 530 Settlement Rd, Ste. A, Gray, GA 31032 Phone: 478-751-4519 |
Highway 18 East Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 324 Highway 18 East, Gray, GA 31032 Phone: 478-751-4519 |
Maggi Califf Street Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 110 Maggie Califf St, Gray, GA 31032 Phone: 478-751-4519 |
West Clinton St Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 502 West Clinton Street, Gray, GA 31032 Phone: 478-751-4519 |
Childs St. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 151 Childs St, Gray, GA 31032 Phone: 478-751-4507 |
Michael Williamson Mft Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 183 W Clinton St, Gray, GA 31032 Phone: 478-227-4189 |
River Edge Behavioral Health Center Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 530 Settlement Rd Ste A, Gray, GA 31032 Phone: 478-751-4507 |
Synergetic Healings Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 183 W Clinton St, Gray, GA 31032 Phone: 478-216-7378 |
News Archive
Study provides evidence to prevent memory decline in older blacks with mild cognitive impairment
With nearly twice the rate of dementia as whites, blacks are at a higher risk for developing diseases like Alzheimer's, but there has been little research on how to reduce this racial health disparity.
Researchers identify barriers to applying international breast cancer guidelines in MENA region
Researchers surveying breast cancer management in the Middle East and North Africa region have identified significant barriers to applying international guidelines in this area, and are calling for localized best practice.
Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine
The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.
Loneliness in older adults during COVID-19 lockdown linked to worsening depressive symptoms
Loneliness in adults aged 50 and over during the COVID-19 lockdown was linked to worsening depressive and other mental health symptoms, according to a large-scale online study.
› Verified 7 days ago